Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
CT conolography has been growing in popularity for several years, largely due to the benefits for patient comfort. New research is now showing advancements and benefits of using machine learning with this method of screening for colon cancer. Look for coverage in the coming days of a study being published later this week.
For more CT colonography coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Pinpointing the correct treatment strategy for patients with acute ischemic stroke can be difficult. But, incorporating MRI with X-ray angiography can make the process easier, leading to improved patient outcomes. Findings published in Radiology recently shows that this combination works well to guide providers in deciding on the best therapy. Keep your eyes open for this story later in the week.
For more coverage acute ischemic stroke, click here.
February is American Heart Month, and state-of-the art, cutting edge cardiovascular imaging is critical to helping providers offer the best heart care possible. This week, Diagnostic Imaging spoke with industry experts about what is on the horizon with cardiovascular imaging. What does the future look like, and what does this mean for both patient and provider? Look for the story later in the week.
For additional coverage on cardiovascular imaging, click here.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.